Evidence map›Paper›PMID 28505101›Full record

ReviewMicroorganisms2017

Dairy Propionibacteria: Versatile Probiotics.

Houem Rabah, Fillipe Luiz Rosa do Carmo, Gwénaël Jan

Abstract readReview
In one paragraph

Review in Microorganisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. A single-nucleotide variant conditions the ability vs. inability ofApplied and environmental microbiology · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Application ofInternational journal of food science · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Snapshot of the Probiotic Potential ofFoods (Basel, Switzerland) · 2023
    Article
  15. Review
  16. Investigation into the Potential Role ofInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Houem RabahUMR 1253 Science et Technologie du Lait et de l'Œuf (STLO), Agrocampus Ouest, INRA, F-35042 Rennes, France. houem.rabah@inra.fr.
Fillipe Luiz Rosa do CarmoUMR 1253 Science et Technologie du Lait et de l'Œuf (STLO), Agrocampus Ouest, INRA, F-35042 Rennes, France. fillipelrc@gmail.com.
Gwénaël JanUMR 1253 Science et Technologie du Lait et de l'Œuf (STLO), Agrocampus Ouest, INRA, F-35042 Rennes, France. gwenael.jan@inra.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dairy propionibacteria are used as cheese ripening starters, as biopreservative and as beneficial additives, in the food industry. The main species, Propionibacterium freudenreichii, is known as GRAS (Generally Recognized As Safe, USA, FDA). In addition to another dairy species, Propionibacterium acidipropionici, they are included in QPS (Qualified Presumption of Safety) list. Additional to their well-known technological application, dairy propionibacteria increasingly attract attention for their promising probiotic properties. The purpose of this review is to summarize the probiotic characteristics of dairy propionibacteria reported by the updated literature. Indeed, they meet the selection criteria for probiotic bacteria, such as the ability to endure digestive stressing conditions and to adhere to intestinal epithelial cells. This is a prerequisite to bacterial persistence within the gut. The reported beneficial effects are ranked according to property's type: microbiota modulation, immunomodulation, and cancer modulation. The proposed molecular mechanisms are discussed. Dairy propionibacteria are described as producers of nutraceuticals and beneficial metabolites that are responsible for their versatile probiotic attributes include short chain fatty acids (SCFAs), conjugated fatty acids, surface proteins, and 1,4-dihydroxy-2-naphtoic acid (DHNA). These metabolites possess beneficial properties and their production depends on the strain and on the growth medium. The choice of the fermented food matrix may thus determine the probiotic properties of the ingested product. This review approaches dairy propionibacteria, with an interest in both technological abilities and probiotic attributes.

Indexed as

dairy propionibacteriadelivery vehiclefermented foodfunctional foodgut microbiotainflammationmetabolitesprobiotic

Identifiers

PMID28505101
PMCPMC5488095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.